NEWS BRIEF · Research journal
A small-molecule TREM2 agonist for Alzheimer’s disease
From the report
Nature Medicine, Published online: 29 October 2026; doi:10.1038/d41591-026-00055-xPreclinical analysis and a phase 1 trial support VG-3927 as a promising drug candidate for Alzheimer’s disease, demonstrating successful penetration of the central nervous system, target engagement and tolerability.
